KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Johnson & Johnson (JNJ) over the last 16 years, with Q3 2025 value amounting to $5.2 billion.

  • Johnson & Johnson's Consolidated Net Income changed N/A to $5.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $21.7 billion, marking a year-over-year increase of 2623012.05%. This contributed to the annual value of $21.8 billion for FY2023, which is 128936.98% up from last year.
  • Per Johnson & Johnson's latest filing, its Consolidated Net Income stood at $5.2 billion for Q3 2025.
  • Johnson & Johnson's 5-year Consolidated Net Income high stood at $21.7 billion for Q4 2023, and its period low was -$232.0 million during Q3 2023.
  • Its 4-year average for Consolidated Net Income is $4.2 billion, with a median of $1.7 billion in 2021.
  • Data for Johnson & Johnson's Consolidated Net Income shows a peak YoY increase of 1457500.0% (in 2023) and a maximum YoY decrease of 14202.9% (in 2023) over the last 5 years.
  • Johnson & Johnson's Consolidated Net Income (Quarter) stood at $3.7 billion in 2021, then tumbled by 95.96% to $148.0 million in 2022, then tumbled by 156.08% to -$83.0 million in 2023, then soared by 6307.23% to $5.2 billion in 2025.
  • Its last three reported values are $5.2 billion in Q3 2025, $5.5 billion for Q2 2025, and $11.0 billion during Q1 2025.